These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 21155862

  • 21. Role of cytokines and chemokines in idiopathic inflammatory myopathies.
    De Paepe B, Creus KK, De Bleecker JL.
    Curr Opin Rheumatol; 2009 Nov; 21(6):610-6. PubMed ID: 19726994
    [Abstract] [Full Text] [Related]

  • 22. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes.
    Authier FJ, Mhiri C, Chazaud B, Christov C, Cherin P, Barlovatz-Meimon G, Gherardi RK.
    Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898
    [Abstract] [Full Text] [Related]

  • 23. [Inflammatory myopathies].
    Cherin P.
    Rev Prat; 2001 Feb 15; 51(3):270-7. PubMed ID: 11265423
    [Abstract] [Full Text] [Related]

  • 24. [Three patients with divergent presentations of idiopathic inflammatory myopathy].
    Bronner IM, van der Meulen MF, Linssen WH, Hoogendijk JE, de Visser M.
    Ned Tijdschr Geneeskd; 2002 May 04; 146(18):833-8. PubMed ID: 12038218
    [Abstract] [Full Text] [Related]

  • 25. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
    Barbasso Helmers S, Dastmalchi M, Alexanderson H, Nennesmo I, Esbjörnsson M, Lindvall B, Lundberg IE.
    Ann Rheum Dis; 2007 Oct 04; 66(10):1276-83. PubMed ID: 17277004
    [Abstract] [Full Text] [Related]

  • 26. Polymyositis: an overdiagnosed entity.
    van der Meulen MF, Bronner IM, Hoogendijk JE, Burger H, van Venrooij WJ, Voskuyl AE, Dinant HJ, Linssen WH, Wokke JH, de Visser M.
    Neurology; 2003 Aug 12; 61(3):316-21. PubMed ID: 12913190
    [Abstract] [Full Text] [Related]

  • 27. Inclusion body myositis: clinical and pathological boundaries.
    Amato AA, Gronseth GS, Jackson CE, Wolfe GI, Katz JS, Bryan WW, Barohn RJ.
    Ann Neurol; 1996 Oct 12; 40(4):581-6. PubMed ID: 8871577
    [Abstract] [Full Text] [Related]

  • 28. The geoepidemiology of autoimmune muscle disease.
    Prieto S, Grau JM.
    Autoimmun Rev; 2010 Mar 12; 9(5):A330-4. PubMed ID: 19906360
    [Abstract] [Full Text] [Related]

  • 29. [New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis].
    Váncsa A, Dankó K.
    Orv Hetil; 2016 Jul 12; 157(30):1179-84. PubMed ID: 27452067
    [Abstract] [Full Text] [Related]

  • 30. Therapeutic approaches in patients with inflammatory myopathies.
    Dalakas MC.
    Semin Neurol; 2003 Jun 12; 23(2):199-206. PubMed ID: 12894385
    [Abstract] [Full Text] [Related]

  • 31. Mitochondrial pathology in immune and inflammatory myopathies.
    Varadhachary AS, Weihl CC, Pestronk A.
    Curr Opin Rheumatol; 2010 Nov 12; 22(6):651-7. PubMed ID: 20827203
    [Abstract] [Full Text] [Related]

  • 32. Plasma cells in muscle in inclusion body myositis and polymyositis.
    Greenberg SA, Bradshaw EM, Pinkus JL, Pinkus GS, Burleson T, Due B, Bregoli L, O'Connor KC, Amato AA.
    Neurology; 2005 Dec 13; 65(11):1782-7. PubMed ID: 16344523
    [Abstract] [Full Text] [Related]

  • 33. Leucocyte/endothelial cell adhesion receptors in muscle biopsies from patients with idiopathic inflammatory myopathies (IIM).
    Cid MC, Grau JM, Casademont J, Tobías E, Picazo A, Coll-Vinent B, Esparza J, Pedrol E, Urbano-Márquez A.
    Clin Exp Immunol; 1996 Jun 13; 104(3):467-73. PubMed ID: 9099932
    [Abstract] [Full Text] [Related]

  • 34. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
    Arahata K, Engel AG.
    Ann Neurol; 1984 Aug 13; 16(2):193-208. PubMed ID: 6383191
    [Abstract] [Full Text] [Related]

  • 35. [Pathogenesis of primary inflammatory myopathies].
    Benveniste O, Squier W, Boyer O, Hilton-Jones D, Herson S.
    Presse Med; 2004 Nov 20; 33(20):1444-50. PubMed ID: 15611679
    [Abstract] [Full Text] [Related]

  • 36. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
    De Paepe B, De Keyzer K, Martin JJ, De Bleecker JL.
    Acta Neuropathol; 2005 Jun 20; 109(6):576-82. PubMed ID: 15937690
    [Abstract] [Full Text] [Related]

  • 37. Detection of the membrane attack complex as a diagnostic tool in dermatomyositis.
    Jain A, Sharma MC, Sarkar C, Bhatia R, Singh S, Gulati S, Handa R.
    Acta Neurol Scand; 2011 Feb 20; 123(2):122-9. PubMed ID: 20497129
    [Abstract] [Full Text] [Related]

  • 38. [Histological data in inflammatory myositis].
    Mikol J, Polivka M.
    Ann Med Interne (Paris); 2001 Nov 20; 152(7):465-79. PubMed ID: 11965088
    [Abstract] [Full Text] [Related]

  • 39. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis.
    Mammen AL.
    Ann N Y Acad Sci; 2010 Jan 20; 1184():134-53. PubMed ID: 20146695
    [Abstract] [Full Text] [Related]

  • 40. Sporadic inclusion body myositis: a continuing puzzle.
    Needham M, Mastaglia FL.
    Neuromuscul Disord; 2008 Jan 20; 18(1):6-16. PubMed ID: 18160291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.